D-0394-2021 Class II Ongoing
FDA drug recall D-0394-2021 was initiated by Noven Pharmaceuticals Inc on May 20, 2021 and is designated Class II. Reason for recall: Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits. The recall status is ongoing. Affected quantity: 6,689 boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 2, 2021
- Initiation Date
- May 20, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,689 boxes
Product description
Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), 30 Patches (NDC 68968-5553-1) per box (NDC 68968-5553-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.
Reason for recall
Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.
Distribution pattern
Nationwide in the USA
Code information
Lot: 88530 Exp. 10/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0394-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026